Schrag, A <br/><br/>
Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challenges.  [electronic resource] 

 -  Movement disorders : official journal of the Movement Disorder Society  Mar 1999 
 - 252-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0885-3185 
<br/><br/><label>Standard No.: </label>10.1002/1531-8257(199903)14:2<252::aid-mds1009>3.0.co;2-n  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiparkinson Agents--pharmacology<br/>Apomorphine--pharmacology<br/>Biperiden--pharmacology<br/>Cholinergic Antagonists--pharmacology<br/>Cross-Over Studies<br/>Dopamine Agonists--pharmacology<br/>Female<br/>Humans<br/>Hypokinesia--drug therapy<br/>Male<br/>Middle Aged<br/>Muscle Rigidity--drug therapy<br/>Parkinson Disease--drug therapy<br/>Single-Blind Method<br/>Tremor--drug therapy